Regional Events and Mentions
By honoring researchers, engineers, and data scientists, we leverage regional convergence to place our community in the context of international breakthroughs for human health.
If you have an event, program, or regional news to share,
please email email@example.com.
Charles River - 2nd Annual World Congress: Lessons Learned from Rare Disease and Personalized Medicine Approaches
September 17-18, 2018; Cambridge, MA
Charles River is proud to host the 2nd Annual World Congress: Lessons Learned from Rare Disease and Personalized Medicine Approaches on September 17-18 at the Royal Sonesta hotel in Cambridge, MA.
The conference agenda is a mix of presentations, panel discussions and short technology demonstrations that will cover a wide range of strategies for successful drug discovery. While the focus of the conference is rare diseases and personalized medicine across various therapeutic areas, there will be a broader discussion around drug discovery approaches and innovative therapeutic modalities that are being employed in the rare disease space.
SoPE NYC: Blockchain in Healthcare - Boom, Bogus, or Bust!
September 26, 2018; New York, NY
Blockchain in healthcare...is it really a revolution? Is it anything more than Bitcoin? Heralded as everything from a complete scam to the most revolutionary technology since the internet, join us as we discuss the practical applications of blockchain in healthcare, its limitations, and the challenges it faces for widespread adoption within the healthcare system.
Sartorius Stedim Biotech - Science On Tap Product Showcase
October 11, 2018; Elmsford, NY
Learn about Sartorius upstream and downstream technology portfolios.
Mingle with your local Sartorius subject matter experts to discuss your specific process or application issues.
Network with your industry peers and like-minded professionals.
November 15, 2018; Liverpool, NY
It all starts here. Our dynamic program boasts two world-class keynotes as well as interactive workshops on Law & Commercialization, Manufacturing Excellence and Biotech Innovation. Get a first-hand look at NEXT generation opportunities, discoveries and products at our Technology Showcase. And stick around for our Networking Reception to connect with other Central New York companies, researchers, manufacturers and investors.
13th Annual New England Venture Summit
December 12, 2018; Lombardo's Conference Center, Boston Randolph, MA
Register using Discount Code WBPVIP
The 13th annual New England Venture Summit, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of venture backed, emerging and early stage companies, university researchers, incubators and premier service providers.
Whether you are an investor seeking access to new deals, or founder and/or CEO of a new venture looking for funding, visibility and growth, The 2018 New England Venture Summit is one event you won't want to miss.
ACRP (Association of Clinical Research Professionals) 2019
April 12-15, 2019; Nashville, TN
Proposal Deadline: August 10, 2018
Help advance the clinical research community by sharing best practices, case studies, practical tips and expertise at ACRP 2019. Submit your proposal to speak and be recognized as a leader, raise your professional profile, and expand your network.Session proposals are sought for one-hour breakout sessions, two-hour ‘masters series’ sessions, four-hour pre-conference workshops, and eight-hour workshops.
ACRP 2019 brings the clinical research community together to learn, connect and explore opportunities to improve operations. Here are a few other highlights of what's in store for 2019:
- 60 Educational Sessions Designed to Improve Operations and Build Professional Competence
- 125+ Thought Leaders and Session Presenters
- 1,200+ Members of the Clinical Research Community
- 100+ Leading-Edge Suppliers and Solutions Providers
FFMI fastPACE; Train-the-Trainer for fastPACE
September 20-21: University of Michigan Workshop
September 28: Conference Call 3-4:30 p
October 5: Conference Call 3-4:30 p
October 12: Conference Call 3-4:30 p
October 19: Live Stream/University of Michigan 12-5 p
Starting September 2018, FFMI will launch its 9th cohort of this 4-week biomedical commercialization and innovation course designed for the busy medical academician with an early stage biomedical product idea. This course blends in-person and online education to help faculty researchers and clinicians prepare a successful business case for funding and partnerships.
In parallel to fastPACE, participating CTSA organizations will have the opportunity to observe our expert teaching team and learn how to launch this program at their home institutions providing their biomedical faculty with the knowledge and tools necessary to navigate the initial process of innovation and commercialization. This 4-week course is a hands-on collaborative learning experience.
News and Articles
ContraFect prices $10M public offering of common stock
July 30, 2018 by Westfair Communications
ContraFect Corp., a Yonkers biotechnology company, announced the pricing of its underwritten public offering of 5 million shares of common stock at $2.00 per share. Proceeds from the offering will be $10 million.
ContraFect also granted the underwriters a 30-day option to purchase up to an additional 750,000 shares. The offering is expected to close on July 31, subject to customary closing conditions.
Sapience Therapeutics Enters into Drug Discovery Pact with the University of Bath
April 5, 2018 - Press Release
HARRISON, NY -- (Marketwired) -- 04/05/18 -- Sapience Therapeutics, Inc., a biotechnology company focused on discovering and developing peptide therapeutics to address difficult to treat oncology indications, announced today that it has entered into a research collaboration agreement with the University of Bath to discover new therapeutic agents.
"We are pleased to be collaborating with Dr. Jody Mason and the University of Bath to discover promising new oncology drugs. Jody has spent over 15 years developing and refining this drug discovery approach and has demonstrated a capacity to generate promising leads against selected targets. This collaboration gives Sapience the opportunity to supplement our ST101 program with a broad pipeline of new peptide therapeutics targeting oncogenic and immune-modulatory protein-protein interactions," said Dr. Barry Kappel, founder and chief executive officer of Sapience Therapeutics. more
Profectus BioSciences leases labs at Pearl River campus
May 24, 2018 by Westfair Communications
Profectus BioSciences, a vaccine maker that focuses on infectious diseases and associated cancers, has leased 39,455 square feet of space for labs and offices at the former Pfizer research campus in Pearl River.
The landlord, Los Angeles-based Industrial Realty Group (IRG), announced the new tenant and a new name for the campus, the New York Center for Innovation.